Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Market Commentary

Tech Stocks Hold Steady Ahead of Pivotal Fed Meeting

Robert Sasse by Robert Sasse
December 9, 2025
in Market Commentary, Nasdaq, Semiconductors, Tech & Software
0
NASDAQ 100 Stock
0
SHARES
32
VIEWS
Share on FacebookShare on Twitter

The Nasdaq 100 index marked time as the new trading week began, with investors adopting a cautious stance in anticipation of the Federal Reserve’s imminent policy decision. Beneath the surface calm, a significant sector rotation provided notable movement. Semiconductor stocks found support from renewed enthusiasm for artificial intelligence, but the index was held back from reaching new highs by pressure on major components like Tesla.

Semiconductor Strength Offsets Tesla Weakness

A divergent picture emerged among the index’s constituents. Broadcom shares advanced 2.3% following reports of advanced talks with Microsoft to develop custom AI chips. This positive sentiment lifted peers such as Micron and Lam Research.

In stark contrast, Tesla shares declined 3.4% after a downgrade by Morgan Stanley. Analysts cited valuation concerns and a weakening demand outlook for electric vehicles in 2026. Marvell Technology was another casualty, falling 7% as investors grew concerned that a potential Broadcom-Microsoft partnership would heighten competitive pressures.

Should investors sell immediately? Or is it worth buying NASDAQ 100?

Merger Speculation Ignites Media Sector

Merger and acquisition rumors also generated activity. Warner Bros. Discovery gained 3.7% on reports of a hostile takeover bid from Paramount Global. Conversely, this news weighed on Netflix, which fell 3.5%, as the market anticipated intensified competition from a potentially strengthened rival.

All Eyes on the Federal Reserve

The prevailing wait-and-see attitude is primarily calendar-driven, with the Fed’s rate decision scheduled for Wednesday. Although the market has firmly priced in a rate cut, uncertainty surrounding the policy outlook for 2026 is prompting investor restraint. Adding to the cautious mood on Monday, rising bond yields dampened risk appetite. The yield on the benchmark 10-year U.S. Treasury note climbed to 4.17%, a move that traditionally pressures the valuations of high-growth technology stocks.

Looking ahead to Tuesday’s session, further hesitation is expected. The Nasdaq 100 closed at 25,698 points. Technically, the broader uptrend remains intact as long as the index holds above the near-term support level at 25,650. However, a break below this level on rising volume could trigger a market correction even before the Fed meeting concludes.

Ad

NASDAQ 100 Stock: Buy or Sell?! New NASDAQ 100 Analysis from March 25 delivers the answer:

The latest NASDAQ 100 figures speak for themselves: Urgent action needed for NASDAQ 100 investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

NASDAQ 100: Buy or sell? Read more here...

Tags: NASDAQ 100
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Alphabet Stock
AI & Quantum Computing

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

March 25, 2026
Coinbase Stock
Analysis

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Intel Stock
Analysis

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

March 25, 2026
Next Post
Omv Stock

OMV Shares Stabilize as Romanian Power Plant Resumes Operations

UBS Stock

UBS Shares Surge on Regulatory Relief and Restructuring Reports

Solana Stock

Institutional Investors Accumulate Solana Amid Market Weakness

Recommended

Marvell Technology Stock

Marvell Technology’s AI Ambitions Face Market Scrutiny After Mixed Results

7 months ago
Safran Stock

Safran Stock: Soars to Record High on Strong Earnings

8 months ago

Fuel Tech Secures 21 Million in Air Pollution Control Contracts

2 years ago
Datadog Stock

Datadog Stock: Soars on Strong Earnings and AI Boom

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

Palo Alto Networks Finalizes Debt Terms Following CyberArk Acquisition

Kuya Silver Shares Show Signs of Technical Recovery

VanEck’s Junior Gold ETF Overhauls Holdings with Major Additions

Trending

Alphabet Stock
AI & Quantum Computing

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

by SiterGedge
March 25, 2026
0

Alphabet CEO Sundar Pichai met with European Union Competition Commissioner Teresa Ribera in San Francisco yesterday. The...

Ocugen Stock

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026
Coinbase Stock

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Unitedhealth Stock

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

March 25, 2026
Intel Stock

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion
  • Ocugen Shares Tumble Despite Positive Clinical Trial Results
  • Regulatory Proposal Sparks Sell-Off in Coinbase Shares

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com